Neu-Isenburg, Germany

Bernd Rosenstock

This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bernd Rosenstock. Retrieved from https://idiyas.com/inventor/bernd-rosenstock

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bernd Rosenstock: Innovator in Antiviral Research

Introduction

Bernd Rosenstock is a notable inventor based in Neu-Isenburg, Germany. He has made significant contributions to the field of antiviral research, particularly through his innovative work on substituted quinoline derivatives. His dedication to advancing medical science is reflected in his patent portfolio.

Latest Patents

Rosenstock holds a patent for "Substituted quinoline derivatives with antiviral action." This invention showcases his commitment to developing new therapeutic agents that can combat viral infections. He has 1 patent to his name, highlighting his innovative contributions to the field.

Career Highlights

Throughout his career, Bernd Rosenstock has been associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work at Hoechst has allowed him to focus on research and development, contributing to advancements in antiviral therapies.

Collaborations

Rosenstock has collaborated with esteemed colleagues, including Reinhard Kirsch and Jorg-Peter Kleim. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

In summary, Bernd Rosenstock is a dedicated inventor whose work in antiviral research has the potential to make a significant impact on public health. His innovative spirit and collaboration with other experts in the field continue to drive advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…